Ty-Jour T1 - 儿童虐待和肺功能：一般人口的调查结果JF - 欧洲呼吸期刊Jo - Eur Respir J Do - 10.1183 / 13993003.02882-2020 SP - 2002882 Au - Spitzer，Carsten Au - Ewert，Ralf Au - völzke，Henry Au - Frenzel，Stefan Au - Felix，Stephan B. Au - Lübke，Laura Au - Grabe，Hans J. Y1 - 2020 / 01/01/01/01/01/01/01/01/01/01/01/01/01/01/01/01/01/01/01/01/01/01 / 01/01/01/01/01/01/0110 / 15/13993003.02882-2020.Abstract N2 - 客观累积证据表明儿童虐待（CM）与自我报告的哮喘和慢性阻塞性肺病有关。然而，尚未评估CM与肺功能肺功能措施的关系尚未评估。在来自一般人群的1386名成年人中，将医疗历史和肺肺功能占用。参与者还完成了儿童创伤问卷，用于评估情绪，身体和性虐待以及情感和身体疏忽。结果25.3％的参与者报告至少一种类型的厘米。其中，使用药物治疗阻塞性气道疾病以及典型的迹象和气流限制的症状明显比在没有暴露于cm的情况下更频繁。尽管CM的参与者对FEV1，FVC和PEF的价值数值较低，但是当核算具有年龄，性别，高度和吸烟等相关协变量时，这些差异是非显着的。同样，无论其定义如何，FEV1 / FVC比率都不存在于气流限制的频率下的差异。没有具体类型的cm与肺功能螺旋测定的参数有关。结论我们的调查结果调用CM与梗阻性肺病的关联，如先前的研究依赖于自我报告的诊断所示。我们考虑对这些差异的几个解释。最近在欧洲呼吸学期刊上被接受了发表的若干解释。 It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. Yan reports grants from National Institutes of Health, during the conduct of the study;.Conflict of interest: Dr. Spitzer has nothing to disclose.Conflict of interest: Dr. Ewert reports lectures fees for Actelion Germany, Janssen Germany, OMT, AstraZeneca, Bayer Vital, GSK, Novartis and Boehringer Ingelheim. Fees for participation on Advisory Board for Actelion, GS and Novartis. .Conflict of interest: Dr. Völzke has nothing to disclose.Conflict of interest: Dr. Frenzel has nothing to disclose.Conflict of interest: Dr. Felix has nothing to disclose.Conflict of interest: Dr. Lübke has nothing to disclose.Conflict of interest: Dr. Grabe reports grants and personal fees from Fresenius Medical Care, personal fees from Neuraxpharm, personal fees from Servier, personal fees from Janssen Cilag, grants from German Research Foundation (DFG), grants from German Ministry of Education and Research (BMBF), grants from DAMP Foundation, grants from EU Joint Program Neurodegenerative Disorders (JPND), grants from European Social Fund (ESF), outside the submitted work. ER -